Maverick Capital · portfolio as of Q2 2026, filed Aug 14, 2026
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
14 of 132 holdings are Undervalued or On Sale by our valuation (5% of the money).
Valued by PaybackPrice; holdings from SEC 13F filings as of Jun 30, 2026. 45 not valued.
Lee Ainslie's portfolio holds 177 stocks worth $31.0B at the end of Q2 2026. The largest positions are ADGI, GUTS, NU, NVDA and AMD.
In Q2 2026, Lee Ainslie opened 84 new positions (ACMR, ASX, ABVX, AEIS, AMKR, APH, ADI, ANET, ARM, ARW, AVT, ACLS, BLTE, AVGO, BF-B, CSCO, CVLT, CRWD, DELL, DIOD, EXTR, META, FFIV, FORM, GEV, HPE, INSM, JJSF, JBL, KLAC, KEYS, KHC, KLIC, LRCX, LSCC, EL, LFUS, MTSI, MXL, MCHP, MU, MDLZ, MPWR, MSI, NTAP, LASR, ON, ONTO, PANW, PFGC, PBH, Q, QCOM, SNDK, SANM, SMTC, SITM, SKYT, SNOW, STM, SLF, SNX, TTMI, TER, TXN, TSN, UMC, UTZ, VECO, MANE, VICR, VOYA, VMC, WDC, CRDO, TROX, STX, TEL, 0Y5E.L, CAMT, NVMI, TSEM, MICC and FLEX) and added to AMD, GOOG, ALAB, BNS, B, BSX, CNI, COF, CVNA, CLS, KO, COMP, DKS, FLR, GFL, INTC, KVUE, KGC, MFC, MMSI, MSFT, MIR, NTRA, NVS, PM, RTX, RGEN, REYN, SNY, SEB, SHW, TD, TPB, PCVX, WPM, DB, NU, ROIV, ALC, BG, LOGI, NAMS and QURE.
In Q2 2026, Lee Ainslie sold out of ABM, AGCO, ABT, ASO, ACHC, ACM, UHAL, AMTM, AR, ARCB, ASTE, AVTR, AVNT, BHE, HRB, BKNG, BC, BKE, BYRN, CVS, CAL, CRC, CALY, CWH, CRI, CELH, CNTA, CRL, CHTR, EXE, CHH, CNK, CFG, CMCO, CON, STZ, CBRL, CXT, CCK, DHR, DRI, PLAY, DAVE, DIS, EQT, EWBC, ENS, EQX, ERIE, ERO, EVH, EXPE, FDX, FITB, FIVE, FRPT, GMED, GL, AGX, HOS, HRL, HBM, HBAN, HUN, INFQ, IART, ITGR, IPAR, INTU, JBI, KBR, KMB, KNX, KR, LH, LAZ, LZ, LMND, LTH, LIF, MSM, MAN, MTCH, MCD, MDLN, MELI, MIDD, MLKN, MITK, MOH, MOS, MUSA, NRG, NTSK, NYT, NOG, OLLI, OSK, PTEN, PENG, PENN, PNFP, PII, DGX, RRC, RRX, RNST, RBLX, ROKU, ROL, ROST, RGLD, SAIA, SAIC, SHG, SIRI, SMA, SNA, SSB, SBUX, STUB, TJX, TMUS, TGT, TECK, TEX, TKR, TNL, TRV, TRIP, TRUP, UPS, WDFC, WMK, WERN, WCC, WAL, WINA, WT, GTES, JHX, ICLR, LIN, LIVN, SPOT and PICS and trimmed ALGM, AMZN, BUD, AMAT, AAOI, TECH, CLX, COHR, CAG, GLW, COTY, EPC, ELAN, ESI, ENTG, GNRC, HSY, LITE, MKSI, MRVL, NVO, PAAS, PRMB, RMBS, SIMO, SWX, SPB, TSM, UCTT, COCO, ICHR and ASML.
COF, NVO, PRMB, MO, SJM, KHC, MU, TFII, CAG, PAAS, SIMO, KGC, B and CLX are Undervalued or On Sale by our valuation.
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
From SEC Form 13F-HR — up to 45 days old at time of filing. Not a recommendation to buy or sell. Analyze any of these free →